Showing 621 - 640 results of 1,766 for search '(( i de decrease ) OR ( 10 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.16s Refine Results
  1. 621

    USING EMBEDDED MACHINE LEARNING IN THE PHYSICAL WORLD TO DETECT TOXICITY IN SPOKEN LANGUAGE by ABU NADA, AHLAM HUSNI

    Published 2023
    “…In our study, quantization demonstrated a significant reduction in model size by almost fourfold and a 3.3-fold decrease in RAM usage. The marginal average F1 score decrease was limited to only 1%. …”
    Get full text
  2. 622
  3. 623

    EPIDEMIOLOGY OF CHLAMYDIA TRACHOMATIS IN LATIN AMERICA AND THE CARIBBEAN: SYSTEMATIC REVIEW, META-ANALYSES, AND META-REGRESSIONS by ABU-EL-RUZ, RASHA

    Published 2022
    “…We estimated the pooled-mean CT prevalence using random-effects meta-analyses. …”
    Get full text
  4. 624
  5. 625
  6. 626
  7. 627

    Wind energy potential along the onshore and offshore Qatar by Mohammed, Aboobacker Valliyil

    Published 2020
    “…cant increase or decrease of wind power around Qatar in the last 40 years in most of the locations, while there is a slight decreasing trend in the o?…”
    Get full text
    Get full text
  8. 628
  9. 629
  10. 630
  11. 631
  12. 632

    Effects of Climate and Atmospheric Nitrogen Deposition on Early to Mid-Term Stage Litter Decomposition Across Biomes by Kwon, Taeoh

    Published 2021
    “…The expected changes in macroclimate and N deposition at the global scale by the end of this century are estimated to increase the 12-month mass loss of easily decomposable litter by 1.1-3.5% and of the more stable substrates by 3.8-10.6%, relative to current mass loss. In contrast, expected changes in atmospheric N deposition will decrease the mid-term mass loss of high-quality litter by 1.4-2.2% and that of low-quality litter by 0.9-1.5% in the temperate biome. …”
    Get full text
    Get full text
    Get full text
  13. 633
  14. 634
  15. 635
  16. 636

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  17. 637
  18. 638
  19. 639
  20. 640